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Grb2 and ShcA are two phosphotyrosine-binding proteins that link receptor protein-tyrosine
kinases to activation of the Ras-Erk pathway. While some receptors bind Grb2 directly, others bind
ShcA, which provides a binding site for Grb2. In order to compare signal transduction through a
Grb2-binding site with signal transduction through a ShcA-binding site, we replaced the ShcA-bind-
ing site in the NGF receptor with a Grb2-binding site. Our results show that the Grb2- and ShcA-bind-
ing sites have similar abilities to activate the Ras-Erk and PI 3-kinase-Akt pathways. In contrast, they
displayed dramatic differences in their ability to activate DNA synthesis.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Receptor protein-tyrosine kinases are activated in response to
extracellular ligands that include migration guidance cues, growth
and differentiation factors, and hormones [1–3]. They regulate di-
verse processes, including cell adhesion, cell migration, differenti-
ation, cell division, cell survival, and metabolism [4]. In general,
receptor protein-tyrosine kinases are activated by ligand-induced
dimerization, followed by cross-phosphorylation on tyrosine resi-
dues present within their kinase domains [4,5]. Active receptors
autophosphorylate tyrosine residues located outside their kinase
domains, thereby creating binding sites for intracellular signaling
proteins [6]. These intracellular signaling proteins are turned on
as a consequence of their interactions with the receptor, resulting
in the activation of signal transduction cascades, including the Ras-
Erk and the PI 3-kinase-Akt pathways [6,7].
Grb2 and ShcA are two receptor-binding proteins that are in-
volved in activation of the Ras-Erk pathway. Grb2 is composed of
an SH2 domain ﬂanked by two SH3 domains [8]. The SH2 domain
is thought to bind to p.Tyr-X-Asn motifs in activated receptors [9].
The amino-terminal SH3 domain binds to the Ras guanine nucleo-
tide exchange factors Sos1 and Sos2 [10]. Grb2-mediated recruit-
ment of Sos to the membrane contributes directly to activation
of the Ras-Erk pathway.chemical Societies. Published by E
n der Geer).
tudy.ShcA proteins are composed of an amino-terminal PTB domain,
a central region that contains tyrosine phosphorylation sites, and a
carboxy-terminal SH2 domain [11,12]. The PTB domain binds to
non-polar-X-Asn-Pro-X-p.Tyr sites [13]. The SH2 domain binds to
phosphorylated tyrosine residues followed by acidic or non-polar
amino acids [9]. ShcA uses its PTB domain to bind to activated
receptor protein-tyrosine kinases. Upon binding, ShcA becomes
phosphorylated on Tyr239, Tyr240, and Tyr317 [14]. Both the Tyr239-
Tyr240Asn241 and the Tyr317Val318Asn319 phosphorylation sites are
thought to function as docking sites for Grb2 [14]. Thus, ShcA plays
a role in the activation of the Ras-Erk pathway by providing recep-
tors with binding sites for Grb2 [15]. Interestingly, some receptors
recruit Grb2-Sos directly, while others recruit this complex indi-
rectly by using a ShcA-binding site. To investigate the possibility
that ShcA contributes more to signal transduction than providing
receptors with a Grb2-binding site, we have compared the signal
transducing abilities of a Grb2- and a ShcA-binding site present
in the context of otherwise identical receptors.
2. Materials and methods
2.1. Reagents
A polyclonal anti-NGF receptor serum was raised against the
carboxy-terminal 18 amino acids. Anti-phosphotyrosine monoclo-
nal antibody 4G10 was purchased from EMD Millipore (Billerica,lsevier B.V. All rights reserved.
S. Oku et al. / FEBS Letters 586 (2012) 3658–3664 3659MA). Rabbit anti-Erk1/2, mouse anti-phospho-Erk1/2 (E10), rabbit
anti-Akt, rabbit anti-phospho-Akt, rabbit anti-Mek1/2, and rabbit
anti-phospho-Mek were purchased from Cell Signaling Technology
(Danvers, MA). BrdU (5-Bromo-20-deoxyuridine) was purchased
from Sigma–Aldrich (St. Louis, MO). Rat anti-BrdU conjugated to
FITC was purchased from AbD Serotec (Raleigh, NC). DAPI (40,6-
diamidino-2-phenylindole) was purchased from Life Technologies
(Grand Island, NY). Recombinant human b NGF was purchased
from R&D Systems (Minneapolis, MN). Protein A-horseradish per-
oxidase was purchased from Biorad (Hercules, CA). Goat anti-
mouse-horseradish peroxidase was purchased from GE Healthcare
Biosciences (Piscataway, NJ).
2.2. Engineering of stable cell lines expressing NGF receptor mutants
Two novel restriction sites (EagI and HpaI) were introduced into
the Phe785 mutant NGF receptor cDNA by PCR-mediated mutagen-
esis. The sequence between the introduced restriction sites en-
codes amino acids 483–496, which includes Tyr490. This sequence
was replaced with complementary oligonucleotides that encode
the various amino acid substitutions around Tyr490. cDNAs were
sequenced to ensure ﬁdelity and cloned into pcDNA3. Mutant
cDNAs were transfected into NIH3T3 cells, which lack endogenous
NGF receptors [16]. Stable clones were selected and maintained in
DMEM containing 10% calf serum and 400 lg/ml G418. Because
receptor expression levels varied considerably between individual
clones, clones with expression levels in the same range were se-
lected for further studies. For experiments, cells were starved over-
night in DMEM containing 20 mM HEPES pH 7.4, stimulated with
NGF at a ﬁnal concentration of 50 ng/ml, unless otherwise noted,
or left unstimulated as a control.
2.3. In vitro binding experiments and immunoblotting
GST-ShcA PTB and GST-Grb2 SH2 domain fusion proteins were
expressed in Escherichia coli, puriﬁed, and tested for their ability to
bind toNGF receptormutants present in cell lysates as described be-
fore [14,17]. Proteins bound to GST-fusion proteins or proteins pres-
ent in whole cell lysates were resolved by SDS–PAGE, transferred to
PVDF membranes, and visualized by immunoblotting as described
before [14]. Immunoblots were quantiﬁed using ImageJ [18].
2.4. BrdU incorporation assay
50  103 cells stably expressing NGF receptor mutants were
seeded on coverslips in 12-well dishes and grown overnight. The
next day cells were washed with PBS, serum-starved for 14 h,
and stimulated with NGF (50 ng/ml) for 10 h. The cells were then
incubated in the presence of 10 lM BrdU for 4 h, rinsed twice with
PBS, incubated in 2 N HCl for 20 min at room temperature and sub-
sequently in 0.1 M boric acid (pH 7.5) for 20 min. Cells were rinsed
with PBS, incubated for 1 h at room temperature with rat anti-
BrdU-FITC diluted 1:40 in PBS containing 5% BSA. The cells were
washed twice with PBS, incubated for 1 min with DAPI (100 ng/
ml in PBS) and washed again with PBS and water. The coverslips
were then mounted on microscope slides with Airvol and the cells
were observed using an inverted ﬂuorescence microscope and pho-
tographed at 200 times magniﬁcation.
3. Results
3.1. Replacing the ShcA-binding site in the NGF receptor with a Grb2-
binding site
To compare signaling downstream of a Grb2-binding site with
signaling downstream of a ShcA-binding site, both sites have tobe present at the same location within the same receptor. Ideally,
the receptor should contain a single tyrosine phosphorylation site
outside its kinase domain. This would minimize contributions of
alternate receptor-binding proteins to signal transduction. The
NGF receptor was chosen as a model because it contains only
two tyrosine phosphorylation sites that act as binding sites for sig-
naling proteins: Tyr490, which binds ShcA, and Tyr785, which binds
PLCc [19]. To eliminate contributions of PLCc to signal transduc-
tion, Tyr785 was mutated to Phe [20]. In the current study, we have
analyzed a receptor containing the wild type ShcA-binding site at
Tyr490 (NGFR-Shc, Fig. 1A), a receptor in which the ShcA-binding
site has been replaced with a Grb2-binding site (NGFR-Grb2,
Fig. 1A), and a receptor that binds neither ShcA nor Grb2 (NGFR-
null, Fig. 1A). To generate the NGFR-null mutant, Ile485 and
Asn487 were mutated to Ser and Ala, respectively (Fig. 1A). To gen-
erate the NGFR-Grb2 mutant, Ile485, Asn487, Phe491, and Ser492 were
mutated to Ser, Ala, Tyr, and Asn, respectively (Fig. 1A). Mutations
were generated in the Phe785 background.
3.2. The Tyr-Tyr-Asn motif acts as a Grb2-binding site in the context of
a receptor protein-tyrosine kinase
Mutant receptors were stably expressed in NIH3T3 cells. To
determine the expression levels, cells were grown to conﬂuence
and NGF receptors were isolated by immunoprecipitation and
visualized by immunoblotting (Fig. 1B). Individual clones were se-
lected for further studies: clones 1–3 express NGFR-Shc; clone 4
expresses NGFR-null; clones 5 and 6 express NGFR-Grb2
(Fig. 1B). To demonstrate that the catalytic activity of the mutant
receptors had not been affected by mutagenesis around Tyr490,
cells were grown to conﬂuence, stimulated with NGF, and ligand-
induced autophosphorylation was evaluated by receptor immuno-
precipitation followed by anti-phosphotyrosine immunoblotting
(Fig. 1C). The results show that all mutant receptors underwent li-
gand-dependent autophosphorylation and that the levels of auto-
phosphorylation ran parallel with receptor expression levels in
the different clones (Fig. 1D).
To demonstrate that we had modiﬁed the binding speciﬁcity of
Tyr490 as predicted, the mutant receptors were tested for their abil-
ity to bind to the ShcA PTB domain and the Grb2 SH2 domain. To
do this, lysates of control and NGF-stimulated cells were incubated
with agarose beads containing GST-ShcA PTB or GST-Grb2 SH2 do-
main fusion proteins. Bound proteins were analyzed by anti-recep-
tor and anti-p.Tyr immunoblotting. NGFR-Shc mutants bound to
the ShcA PTB domain but not to the Grb2 SH2 domain; the
NGFR-Grb2 mutants bound to the Grb2 SH2 domain but not to
the ShcA PTB domain; the NGFR-null mutant bound neither to
the ShcA PTB domain nor to the Grb2 SH2 domain (Fig. 2). These
results conﬁrm that we have generated a pair of NGF receptors
containing a single docking site for signaling proteins at Tyr490 that
binds either ShcA or Grb2. A mutant that binds neither ShcA nor
Grb2 is included in our studies as a negative control.
3.3. Grb2- and ShcA-binding sites show subtle differences in activation
of the Ras-Erk pathway
To compare the signaling ability of the mutant receptors, we
measured NGF-induced activation of the Ras-Erk pathway by prob-
ing whole cell lysates of control and NGF-stimulated cells for the
presence of active MEK and active Erk. NGF receptors that bind nei-
ther Grb2 nor ShcA (NGFR-null) showed no appreciable MEK acti-
vation, receptors that bind Grb2 (NGFR-Grb2) were moderately
strong activators of MEK, while receptors that bind ShcA (NGFR-
Shc) were strong activators of MEK (Fig. 3A). Erk activation paral-
leled MEK activation (Fig. 3B). These results show that activation
of the Ras-Erk pathway in our system depends on signaling
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Fig. 1. Design and expression of NGF receptor mutants. (A) The wild type NGF receptor uses Tyr 490 as a binding site for the PTB domain of ShcA. The ShcA PTB domain binds
to phosphorylated tyrosine residues in the context of a non-polar-X-Asn-Pro-X-p.Tyr motif. To block Shc binding, Ile485 was mutated to Ser and Asn487 was mutated to Ala.
The Grb2 SH2 domain binds to p.Tyr-X-Asn or p.Tyr-p.Tyr-Asn motifs. To generate a Grb2 binding site, Phe491 was mutated to Tyr and Ser492 was mutated to Asn. To block
binding of PLCc to the receptor, Tyr785 was mutated to Phe. Mutants were stably expressed in NIH3T3 cells. (B) Anti-NGF receptor immunoprecipitates were analyzed by anti-
NGF receptor immunoblotting. (C) NGF receptor immunoprecipitates from control and NGF-stimulated cells were analyzed by anti-p.Tyr immunoblotting. (D) The blots in
panels B and C were quantiﬁed and the phosphotyrosine/receptor ratios are shown in the bar graph.
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activation of MEK and Erk than the Grb2-binding site.
3.4. Grb2- and ShcA-binding sites are identical in their ability to
activate the PI 3-kinase-Akt pathway
We studied Akt activation, because Grb2 is linked through
Gab1 to activation of the PI 3-kinase-Akt pathway [21,22].
The results show that receptors that bind either Grb2 or ShcA
triggered robust Akt activation (Fig. 4). In contrast, receptors
that lack binding sites for Grb2 or ShcA were unable to cause
substantial Akt activation (Fig. 4). Thus, in this system, activa-
tion of the PI 3-kinase-Akt pathway depends largely on signal-
ing through Tyr490. In contrast to what we observed with the
Ras-Erk pathway, we found that receptors that bind Grb2 andreceptors that bind ShcA displayed identical abilities to turn
on the PI 3-kinase-Akt pathway.
3.5. Grb2- and ShcA-binding sites exhibit dramatic differences in their
ability to stimulate DNA synthesis
To examine whether the Grb2- and ShcA-binding sites differ in
their ability to stimulate cell division, we analyzed DNA synthesis
in response to NGF by BrdU incorporation. Cells expressing NGFR-
Shc showed a robust increase in DNA synthesis in response to NGF
(Fig. 5, clones 1–3). In contrast, cells expressing NGFR-Grb2
showed only a modest increase in DNA synthesis in response to
NGF (Fig. 5, clones 5 and 6). Cells expressing NGFR-null did not in-
crease DNA synthesis in response to NGF (Fig. 5, clone 4). Thus,
while NGFR-Shc and NGFR-Grb2 show only modest differences in
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GST-ShcA PTB domain fusion proteins immobilized on agarose beads. Bound proteins were analyzed by anti-NGF receptor and anti-p.Tyr immunoblotting. (B) Cell lysates
from control or NGF-stimulated cells were incubated with GST-Grb2 SH2 domain fusion proteins immobilized on agarose beads. Bound proteins were analyzed by anti-NGF
receptor and anti-p.Tyr immunoblotting.
35
NG
FR
-S
hc
NG
FR
-nu
ll
NG
FR
-G
rb2
1 2 3 4 5 6
whole cell lysate
anti-Erk blot
clones
+- - - - - -+ + + + + NGF
Erk-1
Erk-2
35
NG
FR
-S
hc
NG
FR
-nu
ll
NG
FR
-G
rb2
1 2 3 4 5 6
whole cell lysate
anti-p.Erk blot
p.Erk-1
clones
+- - - - - -+ + + + + NGF
p.Erk-2
B
0
1
2
3
4
5
1 2 3 4 5 6 clones
p.
Er
k-
2/
Er
k-
2
55
43
NG
FR
-S
hc
NG
FR
-nu
ll
NG
FR
-G
rb2
1 2 3 4 5 6
whole cell lysate
anti-MEK blot
MEK1/2
clones
+- - - - - -+ + + + + NGF
55
43
NG
FR
-S
hc
NG
FR
-nu
ll
NG
FR
-G
rb2
1 2 3 4 5 6
whole cell lysate
anti-p.MEK blot
p.MEK1/2
clones
+- - - - - -+ + + + + NGF
A
0
1
2
3
4
5
6
7
8
1 2 3 4 5 6 clones
p.
M
EK
/M
EK
Fig. 3. Grb2- and ShcA-binding sites display subtle differences in their ability to activate Erk and MEK. (A) Whole cell lysates of control and NGF-stimulated cells were
resolved by SDS–PAGE and analyzed by anti-phospho-MEK and anti-MEK immunoblotting. The blots were quantiﬁed and the phospho-MEK/MEK ratios are shown in the bar-
graph. (B) Whole cell lysates of control and NGF-stimulated cells were resolved by SDS–PAGE and analyzed by anti-phospho-Erk, and anti-Erk immunoblotting. The blots
were quantiﬁed and the phospho-Erk/Erk ratios are shown in the bar graph.
S. Oku et al. / FEBS Letters 586 (2012) 3658–3664 3661
72
55
NG
FR
-S
hc
NG
FR
-nu
ll
NG
FR
-G
rb2
1 2 3 4
5
6
whole cell lysate
anti-Akt blot
Akt
clones
+- - - - - -+ + + + + NGF
72
55
NG
FR
-S
hc
NG
FR
-nu
ll
NG
FR
-G
rb2
1 2 3 4 5 6
whole cell lysate
anti-p.Akt blot
p.Akt
clones
+- - - - - -+ + + + + NGF
0
1
2
3
4
5
6
7
8
1 2 3 4 5 6 clones
p.
Ak
t/A
kt
Fig. 4. Grb2- and ShcA-binding sites demonstrate identical abilities to activate Akt.
(A) Whole cell lysates of control and NGF-stimulated cells were resolved by SDS–
PAGE and analyzed by anti-phospho-Akt, and anti-Akt immunoblotting. The blots
were quantiﬁed and the phospho-Akt/Akt ratios are shown in the bar graph.
pe
rc
en
ta
ge
 c
el
ls
 s
yn
th
es
iz
in
g 
D
N
A
0
10
20
30
40
50
1 2 3 4 5 6
control
NGF
clones
Fig. 5. The ShcA-binding site demonstrates a stronger ability to support NGF-
dependent DNA synthesis than the Grb2-binding site. NGFR-Shc expressing cells
(clones 1, 2, and 3), NGFR-null expressing cells (clone 4) and, NGFR-Grb2 expressing
cells (clones 5 and 6) were analyzed for NGF-dependent DNA synthesis by BrdU
incorporation. The mean percentages of BrdU positive nuclei are shown, based on
counts in 5 independent samples per data point. The standard deviation is shown as
error bars. The difference in NGF-dependent DNA synthesis between receptors that
bind Grb2 and receptors that bind ShcA is signiﬁcant (p < 0.001).
3662 S. Oku et al. / FEBS Letters 586 (2012) 3658–3664their ability to activate the Ras-Erk and PI 3-kinase-Akt pathways,
they exhibited dramatic differences in their ability to stimulate
DNA synthesis.4. Discussion
Receptor protein-tyrosine kinases use tyrosine phosphorylation
sites to recruit cellular signaling proteins that activate signal trans-
duction pathways [6]. To activate the Ras-MAP kinase pathway,
receptors can recruit Grb2-Sos directly or they can recruit ShcA,
which in turn provides a binding site for Grb2 [23]. It has been
ﬁrmly established that ShcA can provide receptors with a binding
site for Grb2, yet it remains unresolved whether ShcA makes addi-
tional contributions to signal transduction by the activated recep-
tor. To address this question we have compared signal
transduction by NGF receptors that use Tyr 490 as a binding site
for either Grb2 or ShcA.
The NGF receptor was used for this study because it contains
only two tyrosine phosphorylation sites outside its kinase domain
that act as binding sites for signaling proteins: Tyr490, which
binds to ShcA, and Tyr785, which binds to PLCc [19]. This is
important, because past experience has taught us that mutation
of a single phosphorylation site in receptors that autophosphory-
late on many different tyrosine residues often has very little
effect on the activation of individual signal transduction path-
ways [24]. In order to focus our analysis on signal transduction
through the Tyr490 site, Tyr785 was changed to Phe. In the context
of the Phe785 mutation, Tyr490 was changed to a phosphorylation
site that binds Grb2 and to a phosphorylation site that binds nei-
ther ShcA nor Grb2. Thus, we have generated three receptor pro-
tein-tyrosine kinases with a single tyrosine phosphorylation site
outside its kinase domain at Tyr490 that binds Grb2, ShcA or nei-
ther of these proteins.
The ShcA PTB domain has been shown to bind to non-polar-X-
Asn-Pro-X-p.Tyr sites [13]. Consistent with this observation, we
found that changing Ile485 to Ser and Asn487 to Ala abolished bind-
ing of ShcA to the NGF receptor. The Grb2 SH2 domain can bind to
p.Tyr-X-Asn sites [9]. We previously identiﬁed Tyr239 and Tyr240 as
phosphorylation sites in ShcA [14]. Interestingly, these two phos-
phorylation sites form a p.Tyr-p.Tyr-Asn motif that makes impor-
tant contributions to ShcA’s ability to bind Grb2. Here we have
generated a Tyr-Tyr-Asn motif around Tyr490 by changing Phe491
to Tyr and Ser492 to Asn. Our results show, for the ﬁrst time, that
the Tyr-Tyr-Asn motif can function as a bona ﬁde Grb2-binding site
in the context of a receptor protein-tyrosine kinase.
No substantial activation of the Ras-Erk pathway was observed
upon activation of receptor mutants that lacked a binding site for
either Grb2 or ShcA around Tyr490. This conﬁrms that in our sys-
tem, activation of this pathway depends on signaling through
Tyr490. Activation of receptors containing a Tyr-Tyr-Asn motif at
Tyr490 resulted in good activation of the Ras-Erk pathway. This is
consistent with the observation that this sequence can act as a
Grb2-binding site and it provides deﬁnite proof that the Tyr-Tyr-
Asn motif can mediate activation of the Ras-Erk pathway. Recep-
tors containing a ShcA PTB-binding site around Tyr490 displayed
a slightly better ability to activate the Ras-Erk pathway when com-
pared to receptors containing a binding site for the Grb2 SH2 do-
main. This could be explained by the fact that ShcA contains two
possible Grb2-binding sites, suggesting that ShcA functions to in-
crease the number of Grb2 proteins that are recruited to the recep-
tor [14]. Alternatively, ShcA may be using one of its
phosphorylation sites to recruit a novel signaling protein that fur-
ther increases activation of the Ras-Erk pathway (Fig. 6).
Our results further show that NGF receptor mediated activation
of the PI 3-kinase-Akt pathway is largely dependent on the Tyr490
site. Receptors that are unable to use this site to recruit either Grb2
or ShcA proved to be severely deﬁcient in their ability to activate
Akt. This suggests that recruitment of other signaling proteins such
as rAPS and SH2-B to phosphorylated activation loop tyrosines
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pathway [25]. It has previously been established that Grb2 uses
its carboxy-terminal SH3 domain to bind to Gab1; Gab1 provides
binding sites for PI-3 kinase [21,22]. Phosphatidylinositol-3,4,5 tri-
phosphate acts as a docking site for PDK1, an upstream activator
for Akt [26]. In contrast to what we observed when analyzing acti-
vation of the Ras-Erk pathway, both the Grb2-binding site and the
ShcA-binding site appeared to be equally potent in their ability to
activate the PI 3-kinase-Akt pathway. This suggests that signaling
through ShcA, which contains two potential Grb2-binding sites,
does not result in an increase in the recruitment of Grb2 and asso-
ciated proteins to the plasma membrane. This is consistent with
the idea that one of the two phosphorylation sites on ShcA acts
as a binding site for a protein other than Grb2, perhaps an as yet
unidentiﬁed signaling protein (Fig. 6).
While receptors containing a Grb2-binding site and receptors
containing a ShcA-binding site displayed similar abilities to turn
on the Ras-Erk and the PI 3-kinase-Akt pathways, they differed
dramatically in their ability to induce DNA synthesis. There are
some reports that suggest that the docking protein FRS2 binds to
the ShcA-binding site in the NGF receptor [27]. However, it is un-
likely that the difference in the ability to induce DNA synthesis is
mediated by FRS2, because this protein is linked to cell cycle arrest
and differentiation [27,28]. In addition, it is likely that FRS2 is pre-
vented from interacting with NGF receptors in NIH3T3 cells be-
cause of its constitutive interactions with the FGF receptor
[29,30]. The most likely explanation for the difference in ability
to stimulate DNA synthesis is that receptors that bind ShcA acti-
vate a pathway that is not turned on by receptors that bind Grb2
(Fig. 6). ShcA is likely to contribute to activation of this pathway
by recruiting an unidentiﬁed signaling protein to the receptor (rep-
resented by protein X in Fig. 6). By using ShcA-afﬁnity chromatog-
raphy, we have obtained preliminary evidence such that an
unidentiﬁed ShcA-binding protein indeed exists.Our discussion here has focused on ShcA because ShcB, ShcC
and ShcD are primarily expressed in the nervous system and skel-
etal muscle [31]. However, we believe that our conclusions are rel-
evant to understanding the biochemistry of the other Shc family
members, because they all contain two conserved protein-interac-
tion domains and two conserved phosphotyrosine-based protein-
binding motifs [31]. Therefore, all Shc family members are
equipped to recruit several different signaling proteins to activated
receptors.
Acknowledgement
This work was supported in part by the California Metabolic Re-
search Foundation.
References
[1] Perona, R. (2006) Cell signalling: growth factors and tyrosine kinase receptors.
Clin. Transl. Oncol. 8, 77–82.
[2] Forrester, W.C. (2002) The Ror receptor tyrosine kinase family. Cell. Mol. Life.
Sci. 59, 83–96.
[3] Gustafson, T.A., Moodie, S.A. and Lavan, B.E. (1999) The insulin receptor and
metabolic signaling. Rev. Physiol. Biochem. Pharmacol. 137, 71–190.
[4] Schlessinger, J. (2000) Cell signaling by receptor tyrosine kinases. Cell 103,
211–225.
[5] Hubbard, S.R. and Miller, W.T. (2007) Receptor tyrosine kinases: mechanisms
of activation and signaling. Curr. Opin. Cell Biol. 19, 117–123.
[6] Pawson, T. (1995) Protein modules and signalling networks. Nature 373, 573–
580.
[7] Pawson, T., Gish, G.D. and Nash, P. (2001) SH2 domains, interaction modules
and cellular wiring. Trends Cell Biol. 11, 504–511.
[8] Lowenstein, E.J. et al. (1992) The SH2 and SH3 domain-containing protein
GRB2 links receptor tyrosine kinases to ras signaling. Cell 70, 431–442.
[9] Songyang, Z. et al. (1994) Speciﬁc motifs recognized by the SH2 domains of
Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14, 2777–
2785.
[10] Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T. and Bowtell, D. (1993) The
SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras
activator mSos1. Nature 363, 83–85.
3664 S. Oku et al. / FEBS Letters 586 (2012) 3658–3664[11] Pelicci, G. et al. (1992) A novel transforming protein (SHC) with an SH2
domain is implicated in mitogenic signal transduction. Cell 70, 93–104.
[12] Kavanaugh, W.M. and Williams, L.T. (1994) An alternative to SH2 domains for
binding tyrosine-phosphorylated proteins. Science 266, 1862–1865.
[13] van der Geer, P., Wiley, S., Gish, G.D., Lai, V.K., Stephens, R., White, M.F.,
Kaplan, D. and Pawson, T. (1996) Identiﬁcation of residues that control speciﬁc
binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
Proc. Natl. Acad. Sci. U S A 93, 963–968.
[14] van der Geer, P., Wiley, S., Gish, G.D. and Pawson, T. (1996) The Shc
adaptor protein is highly phosphorylated at conserved, twin tyrosine
residues (Y239/240) that mediate protein-protein interactions. Curr. Biol. 6,
1435–1444.
[15] Rozakis-Adcock, M. et al. (1992) Association of the Shc and Grb2/Sem5 SH2-
containing proteins is implicated in the activation of the Ras pathway by
tyrosine kinases. Nature 360, 689–692.
[16] Cordon-Cardo, C. et al. (1991) The trk tyrosine protein kinase mediates the
mitogenic properties of nerved growth factor and neurotrophin-3. Cell 66,
173–183.
[17] van der Geer, P. et al. (1995) A conserved amino-terminal Shc domain binds to
phosphotyrosine motifs in activated growth factor receptors and
phosphopeptides. Curr. Biol. 5, 404–412.
[18] Schneider, C.A., Rasband, W.S. and Eliceiri, K.W. (2012) NIH Image to ImageJ:
25 years of image analysis. Nat. Methods 9, 671–675.
[19] Stephens, R.M., Loeb, D.M., Copeland, T.D., Pawson, T., Greene, L.A. and Kaplan,
D.R. (1994) Trk receptors use redundant signal transduction pathways
involving SHC and PLC-gamma 1 to mediate NGF responses. Neuron 12,
691–705.
[20] Wu, W.-S. (2006) Protein kinase C [alpha] trigger Ras and Raf-independent
MEK/ERK activation for TPA-induced growth inhibition of human hepatoma
cell HepG2. Cancer Lett. 239, 27–35.
[21] Holgado-Madruga, M., Emlet, D.R., Moscatello, D.K., Godwin, A.K. and Wong,
A.J. (1996) A Grb2-associated docking protein in EGF- and insulin-receptor
signalling. Nature 379, 560–564.[22] Fixman, E.D., Holgado-Madruga, M., Nguyen, L., Kamikura, D.M., Fournier,
T.M., Wong, A.J. and Park, M. (1997) Efﬁcient cellular transformation by the
Met oncoprotein requires a functional Grb2 binding site and correlates with
phosphorylation of the Grb2-associated proteins, Cbl and Gab1. J. Biol. Chem.
272, 20167–20172.
[23] Margolis, B. and Skolnik, E.Y. (1994) Activation of Ras by receptor tyrosine
kinases. J. Am. Soc. Nephrol. 5, 1288–1299.
[24] Marshall, C.J. (1995) Speciﬁcity of receptor tyrosine kinase signaling: transient
versus sustained extracellular signal-regulated kinase activation. Cell 80, 179–
185.
[25] Qian, X., Riccio, A., Zhang, Y. and Ginty, D.D. (1998) Identiﬁcation and
characterization of novel substrates of Trk receptors in developing neurons.
Neuron 21, 1017–1029.
[26] Coffer, P.J., Jin, J. and Woodgett, J.R. (1998) Protein kinase B (c-Akt): a
multifunctional mediator of phosphatidylinositol 3-kinase activation.
Biochem. J. 335, 1–13.
[27] Meakin, S.O., MacDonald, J.I., Gryz, E.A., Kubu, C.J. and Verdi, J.M. (1999) The
signaling adapter FRS-2 competes with Shc for binding to the nerve growth
factor receptor TrkA. A model for discriminating proliferation and
differentiation. J. Biol. Chem. 274, 9861–9870.
[28] Zeng, G. and Meakin, S.O. (2002) Overexpression of the signaling adapter FRS2
reconstitutes the cell cycle deﬁcit of a nerve growth factor non-responsive
TrkA receptor mutant. J. Neurochem. 81, 820–831.
[29] Ong, S.H., Guy, G.R., Hadari, Y.R., Laks, S., Gotoh, N., Schlessinger, J. and Lax, I.
(2000) FRS2 proteins recruit intracellular signaling pathways by binding to
diverse targets on ﬁbroblast growth factor and nerve growth factor receptors.
Mol. Cell. Biol. 20, 979–989.
[30] Dhalluin, C. et al. (2000) Structural basis of SNT PTB domain interactions with
distinct neurotrophic receptors. Molecular Cell 6, 921–929.
[31] Jones, N., Hardy, W.R., Friese, M.B., Jorgensen, C., Smith, M.J., Woody, N.M.,
Burden, S.J. and Pawson, T. (2007) Analysis of a Shc family adaptor protein,
ShcD/Shc4, that associates with muscle-speciﬁc kinase. Mol. Cell. Biol. 27,
4759–4773.
